| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850501 | American Heart Journal | 2010 | 9 Pages |
Abstract
The ROCKET AF study will determine the efficacy and safety of rivaroxaban as an alternative to warfarin for the prevention of thromboembolism in patients with AF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
The Executive Steering Committee, on behalf of the ROCKET AF Study Investigators The Executive Steering Committee, on behalf of the ROCKET AF Study Investigators,